Assignee profile:

A&G PHARMACEUTICAL, INC

City:

Columbia, Maryland

Country:

United States

Published Applications:

12

Last publication date:

2016-12-08

Patent Grants:

10

Last grant date:

2014-12-16

Top Inventors for applications by A&G PHARMACEUTICAL, INC

These are the the leading inventors for applications assigned to A&G PHARMACEUTICAL, INC:

Recent patent applications by A&G PHARMACEUTICAL, INC

A&G PHARMACEUTICAL, INC based in Columbia, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-12-08
US20160354452A1
Human necessities

MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE

#2 | 2012-04-12 ✅ Patent 8,911,950 granted on 2014-12-16
US20120087918A1
Human necessities

Methods and compositions for inhibiting the growth of hematopoietic malignant cells

#3 | 2011-09-15
US20110223623A1
Physics

METHODS FOR DIAGNOSING CANCER AND DETERMINING THE OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL OF CANCER PATIENTS

#4 | 2010-01-28 ✅ Patent 8,007,997 granted on 2011-08-30
US20100021475A1
Human necessities

Methods and compositions for inhibiting the growth of hematopoietic malignant cells

#5 | 2009-08-13 ✅ Patent 8,512,960 granted on 2013-08-20
US20090203047A1
Physics

88kDa tumorigenic growth factor and antagonists

#6 | 2009-01-08 ✅ Patent 7,815,906 granted on 2010-10-19
US20090010931A1
Chemistry; metallurgy

Compositions and methods for restoring sensitivity to treatment with HER2 antagonists

#7 | 2008-12-18 ✅ Patent 8,088,373 granted on 2012-01-03
US20080311120A1
Chemistry; metallurgy

Autocrine growth factor receptor antibodies and methods

#8 | 2008-08-12 ✅ Patent 7,411,045 granted on 2008-08-12
US10298540
-

Autocrine growth factor receptor antibodies and methods

#9 | 2006-08-15 ✅ Patent 7,091,047 granted on 2006-08-15
US10281160
-

Methods and kits for diagnosing tumorigenicity

#10 | 2005-05-19 ✅ Patent 7,674,460 granted on 2010-03-09
US20050106150A1
Chemistry; metallurgy

Compositions and methods for restoring sensitivity to treatment with HER2 antagonists

#11 | 2005-04-19 ✅ Patent 6,881,548 granted on 2005-04-19
US9880842
-

Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy

#12 | 2005-02-24 ✅ Patent 7,368,428 granted on 2008-05-06
US20050042225A1
Human necessities

Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis

Also check out A&G PHARMACEUTICAL, INC.'s (Columbia, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

116365 ⎘